We help to protect the strategic interests of our clients
We are the only communications company recognised by the professional financial community
We help shape public images of business leaders and public life
Building strong corporate reputations
Creating communications platforms for international expansion

News archive

Roche Ukraine in honor of the 20th anniversary of the Ukrainian market decided to sum up its activities and develop a strategy for further communication in Ukraine. Roche Ukraine decided to entrust this task to "Mikhailov and Partners. Ukraine" team.

Mikhailov & Partners. Ukraine team conducted a survey among the main stakeholders of Roche Ukraine to identify their expectations and how they perceive the company. According to this research, the agency`s specialists developed a communication strategy for Roche in Ukraine. The key point of the new strategy was to increase availability of innovative treatment for Ukrainian patients.

Main steps of implementation required:

1. Draw attention to the problem of accessibility of innovative treatment for Ukrainian patients.

2. Start a dialogue between all participants of the healthcare sphere in order to increase the availability of innovative and effective treatment through partnership.

The anniversary of Roche in Ukraine became the perfect occasion for communication. Mikhailov & Partners team organized a panel discussion with the participation of officials, patient organizations, doctors, representatives of international and public organizations and the media. About 100 specialists took part in the discussion. The chosen format allowed to present the company's achievements in Ukraine and establish a dialogue between key stakeholders, demonstratedthe company's willingness to work together to ensure the availability of innovative and effective treatment in Ukraine.

Panel discussion was the beginning of a series of events aimed at solving the problem of accessibility of innovative medicine in Ukraine.

Roche is the world leader in the production of innovative drugs for the treatment of serious diseases and investments in research and innovative development. Company is one of the producers of biotechnological drugs in the field of oncology, virology, rheumatology and transplantology. For more than 100 years, Roche has continued to contribute to the global health system.